MiNK Therapeutics, Inc.INKTNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank40
5Y CAGR-3.4%
Studio
Year-over-Year Change

Return on equity

5Y CAGR
-3.4%/yr
Long-term compound
Percentile
P40
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
202455.06%-55.7%
2023124.38%-98.2%
20226975.08%+5589.2%
2021-127.07%-521.6%
202030.14%-54.0%
201965.51%-